Product Code: 5387
The global spirulina protein market is projected to showcase significant expansion through 2022-2030 attributed to the upgrades in technological developments in the industry.
Animal feed producers are increasing their demand for protein-rich diets for livestock feed due to the presence of minimal anti-nutritional factors (ANFs). Companies are also putting forth efforts to safeguard and sustain their supplier base due to unknown shifts in the supply chain mostly during the COVID-19 pandemic.
Additionally, supply management agreements with distributors and dealers are emerging as a key strategy to guarantee that goods are efficiently distributed across all regions.
The spirulina protein market has been bifurcated in terms of species, dosage form, application, and region.
Based on dosage form, the industry has been divided into capsules, powder, tablets, and others. The others segment is slated to witness a CAGR of more than 10.5% over the review timeline. This is credited to the growing preference for spirulina protein products such as gummies, given the ease of consumption of these dosage forms.
With respect to application, the bakery & confectionery segment is set to register more than 8% CAGR through 2030, due to the changing trend toward vegan and organic nutrition. Naturally-sourced ingredients such as spirulina protein are becoming increasingly used in healthier confectionary and bakery products, contributing to market development.
Meanwhile, the snacks segment is expected to exhibit a CAGR of over 8% over the forecast period, due to the shift in focus of snack manufacturers on nutrient enrichment through the use of ingredients such as spirulina protein.
The pharmaceuticals application segment is estimated to record a CAGR of over 8.5% through 2030, given the ability of spirulina protein supplements to enhance medicinal drugs.
The animal feed segment is poised to register more than 7.5% CAGR between 2022 and 2030, driven by the expanding animal-rearing sector, and the subsequent increase in demand for nutrient-rich animal feed products.
The cosmetics segment is expected to record over 7% CAGR through 2022-2030, due to the use of spirulina protein products in skin care products such as creams and lotions.
From the regional perspective, the Middle East & Africa spirulina protein market is likely to register commendable growth over the forecast spell, owing to new technological advancements and the introduction of cutting-edge functional food products in the region.
Meanwhile, the Latin America spirulina protein industry is estimated to expand at a substantial growth rate through 2032, fueled by favorable factors such as foreign direct investments, attractive trade policies in the pharmaceutical sector, and improvements in the food and beverage sector.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market definitions
- 1.2 Base estimates & calculations
- 1.3 Forecast parameters
- 1.4 Data Sources
- 1.4.1 Primary
- 1.4.2 Secondary
- 1.4.2.1 Paid Sources
- 1.4.2.2 Public Sources
Chapter 2 Executive Summary
- 2.1 Spirulina protein application 360 degree synopsis, 2018 - 2030
- 2.1.1 Business trends
- 2.1.2 Regional trends
- 2.1.3 Species Trends
- 2.1.4 Dosage form trends
- 2.1.5 Application trends
Chapter 3 Spirulina Protein Industry Insights
- 3.1 Industry segmentation
- 3.2 COVID-19 impact on world economy
- 3.3 Industry ecosystem analysis
- 3.3.1 Vendor matrix
- 3.3.2 Distribution channel analysis
- 3.4 Technology landscape
- 3.5 Insect analysis
- 3.6 Raw material trends
- 3.6.1 Cost structure analysis
- 3.7 Regulatory landscape
- 3.7.1 U.S.
- 3.7.2 Europe
- 3.7.3 China
- 3.8 Pricing analysis, by region
- 3.8.1 Regional pricing
- 3.8.1.1 North America
- 3.8.1.2 Europe
- 3.8.1.3 Asia Pacific
- 3.8.1.4 Latin America
- 3.8.1.5 MEA
- 3.8.1.6 Covid-19 impact on spirulina protein prices
- 3.9 Industry impact forces
- 3.9.1 Growth drivers
- 3.9.1.1 The rising demand for dietary supplements industry
- 3.9.1.2 Increasing demand for protein-rich diets for animal feed from animal feed manufacturers owing to its highly digestible minimized anti-nutritional factors (ANFs) presence
- 3.9.1.3 Constantly developing food demand globally
- 3.9.2 Industry pitfalls & challenges
- 3.9.2.1 Limited knowledge regarding the benefits of Spirulina consumption
- 3.9.2.2 The complex production process of algae based products Innovation & sustainability
- 3.10 Growth potential analysis, 2021
- 3.11 Porter's analysis
- 3.12 PESTEL analysis
- 3.13 Russia-Ukraine War impact on spirulina protein application
- 3.14 COVID-19 impact on alternate protein market
Chapter 4 Competitive Landscape, 2021
- 4.1 Introduction
- 4.2 Company market share, 2021
- 4.3 Strategy dashboard
- 4.4 Key stakeholders
Chapter 5 Spirulina Protein Market, By Species
- 5.1 Key species trends
- 5.2 Arthrospira Plantesis
- 5.2.1 Market estimates and forecast, 2018 - 2030
- 5.2.2 Market estimates and forecast, by region, 2018 - 2030
- 5.3 Arthrospira Maxima
- 5.3.1 Market estimates and forecast, 2018 - 2030
- 5.3.2 Market estimates and forecast, by region, 2018 - 2030
- 5.4 Others
- 5.4.1 Market estimates and forecast, 2018 - 2030
- 5.4.2 Market estimates and forecast, by region, 2018 - 2030
Chapter 6 Spirulina Protein Market, By Dosage Form
- 6.1 Key dosage form trends
- 6.2 Capsules
- 6.2.1 Market estimates and forecast, 2018 - 2030
- 6.2.2 Market estimates and forecast, by region, 2018 - 2030
- 6.3 Powder
- 6.3.1 Market estimates and forecast, 2018 - 2030
- 6.3.2 Market estimates and forecast, by region, 2018 - 2030
- 6.4 Tablets
- 6.4.1 Market estimates and forecast, 2018 - 2030
- 6.4.2 Market estimates and forecast, by region, 2018 - 2030
Chapter 7 Spirulina Protein Market, By Application
- 7.1 Key application trends
- 7.2 Dietary Supplements
- 7.2.1 Market estimates and forecast, 2018 - 2030
- 7.2.2 Market estimates and forecast, by region, 2018 - 2030
- 7.3 Functional Food & Beverages
- 7.3.1 Market estimates and forecast, 2018 - 2030
- 7.3.2 Market estimates and forecast, by region, 2018 - 2030
- 7.3.3 Bakery & Confectionery
- 7.3.3.1 Market estimates and forecast, 2018 - 2030
- 7.3.3.2 Market estimates and forecast, by region, 2018 - 2030
- 7.3.4 Breakfast Cereals
- 7.3.4.1 Market estimates and forecast, 2018 - 2030
- 7.3.4.2 Market estimates and forecast, by region, 2018 - 2030
- 7.3.5 Snacks
- 7.3.5.1 Market estimates and forecast, 2018 - 2030
- 7.3.5.2 Market estimates and forecast, by region, 2018 - 2030
- 7.4 Pharmaceuticals
- 7.4.1 Market estimates and forecast, 2018 - 2030
- 7.4.2 Market estimates and forecast, by region, 2018 - 2030
- 7.5 Animal Feed
- 7.5.1 Market estimates and forecast, 2018 - 2030
- 7.5.2 Market estimates and forecast, by region, 2018 - 2030
- 7.5.3 Poultry
- 7.5.3.1 Market estimates and forecast, 2018 - 2030
- 7.5.3.2 Market estimates and forecast, by region, 2018 - 2030
- 7.5.4 Swine
- 7.5.4.1 Market estimates and forecast, 2018 - 2030
- 7.5.4.2 Market estimates and forecast, by region, 2018 - 2030
- 7.5.5 Cattle
- 7.5.5.1 Market estimates and forecast, 2018 - 2030
- 7.5.5.2 Market estimates and forecast, by region, 2018 - 2030
- 7.5.6 Aquaculture
- 7.5.6.1 Market estimates and forecast, 2018 - 2030
- 7.5.6.2 Market estimates and forecast, by region, 2018 - 2030
- 7.5.7 Pet Food
- 7.5.7.1 Market estimates and forecast, 2018 - 2030
- 7.5.7.2 Market estimates and forecast, by region, 2018 - 2030
- 7.5.8 Others
- 7.5.8.1 Market estimates and forecast, 2018 - 2030
- 7.5.8.2 Market estimates and forecast, by region, 2018 - 2030
- 7.6 Cosmetics
- 7.6.1 Market estimates and forecast, 2018 - 2030
- 7.6.2 Market estimates and forecast, by region, 2018 - 2030
- 7.7 Others
- 7.7.1 Market estimates and forecast, 2018 - 2030
- 7.7.2 Market estimates and forecast, by region, 2018 - 2030
Chapter 8 Spirulina protein Application, By Region
- 8.1 Key regional trend
- 8.2 North America
- 8.2.1 Market estimates and forecast, 2018 - 2030
- 8.2.2 Market estimates and forecast, by species, 2018 - 2030
- 8.2.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.2.4 Market estimates and forecast, by application, 2018 - 2030
- 8.2.5 U.S.
- 8.2.5.1 Market estimates and forecast, 2018 - 2030
- 8.2.5.2 Market estimates and forecast, by species, 2018 - 2030
- 8.2.5.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.2.5.4 Market estimates and forecast, by application, 2018 - 2030
- 8.2.6 Canada
- 8.2.6.1 Market estimates and forecast, 2018 - 2030
- 8.2.6.2 Market estimates and forecast, by species, 2018 - 2030
- 8.2.6.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.2.6.4 Market estimates and forecast, by application, 2018 - 2030
- 8.3 Europe
- 8.3.1 Market estimates and forecast, 2018 - 2030
- 8.3.2 Market estimates and forecast, by species, 2018 - 2030
- 8.3.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.3.4 Market estimates and forecast, by application, 2018 - 2030
- 8.3.5 Germany
- 8.3.5.1 Market estimates and forecast, 2018 - 2030
- 8.3.5.2 Market estimates and forecast, by species, 2018 - 2030
- 8.3.5.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.3.5.4 Market estimates and forecast, by application, 2018 - 2030
- 8.3.6 UK
- 8.3.6.1 Market estimates and forecast, 2018 - 2030
- 8.3.6.2 Market estimates and forecast, by species, 2018 - 2030
- 8.3.6.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.3.6.4 Market estimates and forecast, by application, 2018 - 2030
- 8.3.7 France
- 8.3.7.1 Market estimates and forecast, 2018 - 2030
- 8.3.7.2 Market estimates and forecast, by species, 2018 - 2030
- 8.3.7.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.3.7.4 Market estimates and forecast, by application, 2018 - 2030
- 8.3.8 Italy
- 8.3.8.1 Market estimates and forecast, 2018 - 2030
- 8.3.8.2 Market estimates and forecast, by species, 2018 - 2030
- 8.3.8.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.3.8.4 Market estimates and forecast, by application, 2018 - 2030
- 8.3.9 Russia
- 8.3.9.1 Market estimates and forecast, 2018 - 2030
- 8.3.9.2 Market estimates and forecast, by species, 2018 - 2030
- 8.3.9.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.3.9.4 Market estimates and forecast, by application, 2018 - 2030
- 8.3.10 Spain
- 8.3.10.1 Market estimates and forecast, 2018 - 2030
- 8.3.10.2 Market estimates and forecast, by species, 2018 - 2030
- 8.3.10.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.3.10.4 Market estimates and forecast, by application, 2018 - 2030
- 8.3.11 Netherlands
- 8.3.11.1 Market estimates and forecast, 2018 - 2030
- 8.3.11.2 Market estimates and forecast, by species, 2018 - 2030
- 8.3.11.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.3.11.4 Market estimates and forecast, by application, 2018 - 2030
- 8.3.12 Poland
- 8.3.12.1 Market estimates and forecast, 2018 - 2030
- 8.3.12.2 Market estimates and forecast, by species, 2018 - 2030
- 8.3.12.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.3.12.4 Market estimates and forecast, by application, 2018 - 2030
- 8.4 Asia Pacific
- 8.4.1 Market estimates and forecast, 2018 - 2030
- 8.4.2 Market estimates and forecast, by species, 2018 - 2030
- 8.4.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.4.4 Market estimates and forecast, by application, 2018 - 2030
- 8.4.5 China
- 8.4.5.1 Market estimates and forecast, 2018 - 2030
- 8.4.5.2 Market estimates and forecast, by species, 2018 - 2030
- 8.4.5.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.4.5.4 Market estimates and forecast, by application, 2018 - 2030
- 8.4.6 India
- 8.4.6.1 Market estimates and forecast, 2018 - 2030
- 8.4.6.2 Market estimates and forecast, by species, 2018 - 2030
- 8.4.6.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.4.6.4 Market estimates and forecast, by application, 2018 - 2030
- 8.4.7 Japan
- 8.4.7.1 Market estimates and forecast, 2018 - 2030
- 8.4.7.2 Market estimates and forecast, by species, 2018 - 2030
- 8.4.7.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.4.7.4 Market estimates and forecast, by application, 2018 - 2030
- 8.4.8 South Korea
- 8.4.8.1 Market estimates and forecast, 2018 - 2030
- 8.4.8.2 Market estimates and forecast, by species, 2018 - 2030
- 8.4.8.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.4.8.4 Market estimates and forecast, by application, 2018 - 2030
- 8.4.9 Australia
- 8.4.9.1 Market estimates and forecast, 2018 - 2030
- 8.4.9.2 Market estimates and forecast, by species, 2018 - 2030
- 8.4.9.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.4.9.4 Market estimates and forecast, by application, 2018 - 2030
- 8.4.10 Thailand
- 8.4.10.1 Market estimates and forecast, 2018 - 2030
- 8.4.10.2 Market estimates and forecast, by species, 2018 - 2030
- 8.4.10.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.4.10.4 Market estimates and forecast, by application, 2018 - 2030
- 8.4.11 Indonesia
- 8.4.11.1 Market estimates and forecast, 2018 - 2030
- 8.4.11.2 Market estimates and forecast, by species, 2018 - 2030
- 8.4.11.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.4.11.4 Market estimates and forecast, by application, 2018 - 2030
- 8.4.12 Malaysia
- 8.4.12.1 Market estimates and forecast, 2018 - 2030
- 8.4.12.2 Market estimates and forecast, by species, 2018 - 2030
- 8.4.12.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.4.12.4 Market estimates and forecast, by application, 2018 - 2030
- 8.5 Latin America (LATAM)
- 8.5.1 Market estimates and forecast, 2018 - 2030
- 8.5.2 Market estimates and forecast, by species, 2018 - 2030
- 8.5.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.5.4 Market estimates and forecast, by application, 2018 - 2030
- 8.5.5 Brazil
- 8.5.5.1 Market estimates and forecast, 2018 - 2030
- 8.5.5.2 Market estimates and forecast, by species, 2018 - 2030
- 8.5.5.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.5.5.4 Market estimates and forecast, by application, 2018 - 2030
- 8.5.6 Argentina
- 8.5.6.1 Market estimates and forecast, 2018 - 2030
- 8.5.6.2 Market estimates and forecast, by species, 2018 - 2030
- 8.5.6.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.5.6.4 Market estimates and forecast, by application, 2018 - 2030
- 8.5.7 Mexico
- 8.5.7.1 Market estimates and forecast, 2018 - 2030
- 8.5.7.2 Market estimates and forecast, by species, 2018 - 2030
- 8.5.7.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.5.7.4 Market estimates and forecast, by application, 2018 - 2030
- 8.6 Middle East & Africa (MEA)
- 8.6.1 Market estimates and forecast, 2018 - 2030
- 8.6.2 Market estimates and forecast, by species, 2018 - 2030
- 8.6.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.6.4 Market estimates and forecast, by application, 2018 - 2030
- 8.6.5 Saudi Arabia
- 8.6.5.1 Market estimates and forecast, 2018 - 2030
- 8.6.5.2 Market estimates and forecast, by species, 2018 - 2030
- 8.6.5.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.6.5.4 Market estimates and forecast, by application, 2018 - 2030
- 8.6.6 UAE
- 8.6.6.1 Market estimates and forecast, 2018 - 2030
- 8.6.6.2 Market estimates and forecast, by species, 2018 - 2030
- 8.6.6.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.6.6.4 Market estimates and forecast, by application, 2018 - 2030
- 8.6.7 South Africa
- 8.6.7.1 Market estimates and forecast, 2018 - 2030
- 8.6.7.2 Market estimates and forecast, by species, 2018 - 2030
- 8.6.7.3 Market estimates and forecast, by dosage form, 2018 - 2030
- 8.6.7.4 Market estimates and forecast, by application, 2018 - 2030
Chapter 9 Company Profiles
- 9.1 ENERGYbits Inc.
- 9.1.1 Business Overview
- 9.1.2 Financial Data
- 9.1.3 Product Landscape
- 9.1.4 SWOT Analysis
- 9.1.5 Strategic Outlook
- 9.2 Far East Bio-Tec Co. Ltd.
- 9.2.1 Business Overview
- 9.2.2 Financial Data
- 9.2.3 Product Landscape
- 9.2.4 SWOT Analysis
- 9.2.5 Strategic Outlook
- 9.3 Nutrex Hawaii Inc.
- 9.3.1 Business Overview
- 9.3.2 Financial Data
- 9.3.3 Product Landscape
- 9.3.4 SWOT Analysis
- 9.3.5 Strategic Outlook
- 9.4 E.I.D Parry (India) Ltd.
- 9.4.1 Business Overview
- 9.4.2 Financial Data
- 9.4.3 Product Landscape
- 9.4.4 SWOT Analysis
- 9.4.5 Strategic Outlook
- 9.5 Earthrise Nutritionals LLC (DIC Corporation)
- 9.5.1 Business Overview
- 9.5.2 Financial Data
- 9.5.3 Product Landscape
- 9.5.4 SWOT Analysis
- 9.5.5 Strategic Outlook
- 9.6 Phycom Microalgae
- 9.6.1 Business Overview
- 9.6.2 Financial Data
- 9.6.3 Product Landscape
- 9.6.4 SWOT Analysis
- 9.6.5 Strategic Outlook
- 9.7 Cyanotech Corporation
- 9.7.1 Business Overview
- 9.7.2 Financial Data
- 9.7.3 Product Landscape
- 9.7.4 SWOT Analysis
- 9.7.5 Strategic Outlook
- 9.8 JUNE Group of Companies (JUNE Spirulina)
- 9.8.1 Business Overview
- 9.8.2 Financial Data
- 9.8.3 Product Landscape
- 9.8.4 SWOT Analysis
- 9.8.5 Strategic Outlook
- 9.9 Yunnan Green A Biological Project Co., Ltd
- 9.9.1 Business Overview
- 9.9.2 Financial Data
- 9.9.3 Product Landscape
- 9.9.4 SWOT Analysis
- 9.9.5 Strategic Outlook
- 9.10 Fuqing King Dnarmsa Spirulina Co., Ltd.
- 9.10.1 Business Overview
- 9.10.2 Financial Data
- 9.10.3 Product Landscape
- 9.10.4 SWOT Analysis
- 9.10.5 Strategic Outlook
- 9.11 Prolgae Spirulina Supplies Pvt. Ltd.
- 9.11.1 Business Overview
- 9.11.2 Financial Data
- 9.11.3 Product Landscape
- 9.11.4 SWOT Analysis
- 9.11.5 Strategic Outlook
- 9.12 Naturalin Bio-Resources Co., Ltd.
- 9.12.1 Business Overview
- 9.12.2 Financial Data
- 9.12.3 Product Landscape
- 9.12.4 SWOT Analysis
- 9.12.5 Strategic Outlook